Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
Namenda, Namenda XR Titration Pack, Namenda XR
Synonyms :
Class :
N-Methyl-D-Aspartate (NMDA) Receptor Antagonist
Dosage Forms & Strengths Â
Tablet-(Oral, as hydrochloride) Â
5mg Â
10mg Â
Capsule-ER (Oral, as hydrochloride) Â
7mg Â
14mg Â
28mg Â
Oral solution (Oral, as hydrochloride) Â
2mg/mLÂ
5 mg tablet orally may be increased up to 5 mg/day each week. Maintenance dose: 20 mg/day orally twice a day 7 mg PO Capsule-ER may be increased up to 7 mg/day each week Maintenance dose: 28 mg/day orally daily
5 mg tablet orally may be increased up to 5 mg/day each week.
Maintenance dose: 20 mg/day orally twice a day
7 mg PO Capsule-ER daily, may be increased up to 7 mg/day each week
Maintenance dose: 28 mg/day orally daily
Not indicatedÂ
it may increase the level of serum concentration of memantine
it may increase the level of serum concentration of memantine
it may increase the level of serum concentration of memantine
it may increase the level of serum concentration of memantine
it may increase the level of serum concentration of memantine
it may increase the level of serum concentration of memantine
it may increase the level of serum concentration of memantine
it may increase the level of serum concentration of memantine
it may increase the level of serum concentration of memantine
it may increase the level of serum concentration of memantine
it may increase the risk of adverse effects of memantine
it may increase the risk of adverse effects of memantine
it may increase the risk of adverse effects of memantine
it may increase the risk of adverse effects of memantine
it may increase the risk of adverse effects of memantine
It may enhance the serum concentration when combined with alkalinizing agents
It may enhance the serum concentration when combined with alkalinizing agents
It may enhance the serum concentration when combined with alkalinizing agents
It may enhance the serum concentration when combined with alkalinizing agents
It may enhance the serum concentration when combined with alkalinizing agents
memantine: they may enhance the serum concentration of alkalinizing agents
memantine: they may enhance the serum concentration of alkalinizing agents
memantine: they may enhance the serum concentration of alkalinizing agents
memantine: they may enhance the serum concentration of alkalinizing agents
memantine: they may enhance the serum concentration of alkalinizing agents
When memantine is used together with profenamine, this leads to enhanced risk or seriousness of adverse events
memantine: it may increase the risk of adverse effects with CYP3A4 inhibitors
memantine: it may increase the risk of adverse effects with CYP3A4 inhibitors
memantine: it may increase the risk of adverse effects with CYP3A4 inhibitors
memantine: it may increase the risk of adverse effects with CYP3A4 inhibitors
memantine: it may increase the risk of adverse effects with CYP3A4 inhibitors
it may increase the risk of adverse effects of memantine 
it may increase the risk of adverse effects of memantine
may increase the toxic effect of NMDA receptor antagonists
trimethoprim: they may increase the toxic effect of memantine
Adverse drug reactions:  Â
Frequency Defined Â
1-10% Â
Headache (6%) Â
Constipation (5%) Â
Dizziness (7%) Â
Cough (4%) Â
Syncope (3%) Â
Vomiting (3%) Â
Dyspnea (2%) Â
Fatigue (2%) Â
Hypertension (4%) Â
Confusion (6%) Â
Backache (3%) Â
Pain (3%) Â
Somnolence (3%) Â
 Â
 Â
Pregnancy warnings:    
Pregnancy Category: N/AÂ Â
Lactation: not knownÂ
Pregnancy Categories:      Â
Patient Information Leaflet   Â
Generic Name: memantine (Rx)Â
Why do we use memantine (Rx)?Â
memantine (Rx) belongs to the class of NMDA Antagonists, which helps to treat Alzheimer’s disease and Dementia.Â